Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118751763 | 11875176 | 3 | F | 20160705 | 20151229 | 20160716 | EXP | US-AUROBINDO-AUR-APL-2015-11649 | AUROBINDO | 23.00 | YR | F | Y | 0.00000 | 20160716 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118751763 | 11875176 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Unknown | 500 MG, TWO TIMES A DAY | N | U | 77859 | 500 | MG | BID | |||||
118751763 | 11875176 | 2 | SS | Moxifloxacin 400mg | MOXIFLOXACIN | 1 | Unknown | 400 MG, DAILY | N | U | 0 | 400 | MG | ||||||
118751763 | 11875176 | 3 | SS | Moxifloxacin 400mg | MOXIFLOXACIN | 1 | N | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
118751763 | 11875176 | 1 | Diarrhoea infectious |
118751763 | 11875176 | 2 | Oropharyngeal pain |
118751763 | 11875176 | 3 | Pyrexia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
118751763 | 11875176 | DS |
118751763 | 11875176 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
118751763 | 11875176 | Abdominal pain | |
118751763 | 11875176 | Alopecia | |
118751763 | 11875176 | Amnesia | |
118751763 | 11875176 | Arthralgia | |
118751763 | 11875176 | Asthenia | |
118751763 | 11875176 | Autonomic nervous system imbalance | |
118751763 | 11875176 | Cognitive disorder | |
118751763 | 11875176 | Decreased appetite | |
118751763 | 11875176 | Diarrhoea | |
118751763 | 11875176 | Disturbance in attention | |
118751763 | 11875176 | Dizziness | |
118751763 | 11875176 | Dry eye | |
118751763 | 11875176 | Dry mouth | |
118751763 | 11875176 | Dyspnoea | |
118751763 | 11875176 | Fatigue | |
118751763 | 11875176 | Gastrointestinal pain | |
118751763 | 11875176 | Gastrooesophageal reflux disease | |
118751763 | 11875176 | Hypoaesthesia | |
118751763 | 11875176 | Hypotension | |
118751763 | 11875176 | Impaired gastric emptying | |
118751763 | 11875176 | Inflammation | |
118751763 | 11875176 | Insomnia | |
118751763 | 11875176 | Intestinal metaplasia | |
118751763 | 11875176 | Irritable bowel syndrome | |
118751763 | 11875176 | Micturition urgency | |
118751763 | 11875176 | Migraine | |
118751763 | 11875176 | Mood swings | |
118751763 | 11875176 | Muscle contractions involuntary | |
118751763 | 11875176 | Myalgia | |
118751763 | 11875176 | Mydriasis | |
118751763 | 11875176 | Nausea | |
118751763 | 11875176 | Orthostatic intolerance | |
118751763 | 11875176 | Paraesthesia | |
118751763 | 11875176 | Polyneuropathy | |
118751763 | 11875176 | Postural orthostatic tachycardia syndrome | |
118751763 | 11875176 | Seizure | |
118751763 | 11875176 | Sinusitis | |
118751763 | 11875176 | Skin burning sensation | |
118751763 | 11875176 | Tachycardia | |
118751763 | 11875176 | Tendonitis | |
118751763 | 11875176 | Toxicity to various agents | |
118751763 | 11875176 | Ulcerative keratitis | |
118751763 | 11875176 | Upper respiratory tract infection | |
118751763 | 11875176 | Vomiting | |
118751763 | 11875176 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |